Previous studies have indicated an association between amyloidogenesis and GAP-43 or BDNF in CSF samples of patients with AD (Sandelius et al., 2019; Mahaman et al., 2021; Simrén et al., 2023). This evidence concerns the gene GAP43 and Alzheimer disease.